Drug trial shows efficacy in treating anemia in chronic kidney disease patients without dialysis
FibroGen, Inc. today announced publication of results from the Phase 3 trial of the efficacy and safety of roxadustat treatment compared to placebo for anemia in non-dialysis patients (NDD) with chronic kidney disease (CKD) ...
Jul 25, 2019
0
2